Building clinical pathways.

S M Leininger

PubMed · 9847822

Building clinical pathways.

Abstract

TQM principles change the work environment so that point-of-service personnel can improve health care delivery to patients. The clinical pathway process starts with the principles of TQM. In the era of managed care, health care resources can be managed effectively using a clinical pathway. The multidisciplinary team has the opportunity to improve the health care services provided to patients.

Explore related subjects

Communication Critical Pathways Humans Interprofessional Relations Leadership Patient Care Team Program Development Total Quality Management Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S M Leininger. Building clinical pathways.. https://pubmed.ncbi.nlm.nih.gov/9847822/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

The social psychology of public response to warnings of a nuclear power plant accident.

This article reviews the process of public response to warnings of an impending nuclear power plant emergency. Significant evidence exists to suggest that people engage in protective action in response to warnings based upon the substance and course through which emergency warning information is disseminated. The three basic components of a warning system are defined, and the elements of public response to warnings are summarized. Popular myths about public response to warnings are outlined and dispelled based upon current research verification. The conclusion provides an overview and synthesis of the warning response process.

Communication↗

PubMed2000

[Past, present, and future of "Letter to the editor" as a form of scientific communication].

Explore the source record for details and available documents.

Communication↗

PubMed2000

Treating nondementia illnesses in patients with dementia.

Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia. However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials. JAMA. 2000;283:3230-3235

Communication↗